The regulation of muscle mass by endogenous glucocorticoids

被引:181
|
作者
Braun, Theodore P. [1 ,2 ]
Marks, Daniel L. [1 ]
机构
[1] Univ Washington, Med Ctr, Dept Internal Med, Seattle, WA 98195 USA
[2] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97239 USA
来源
FRONTIERS IN PHYSIOLOGY | 2015年 / 6卷
基金
加拿大健康研究院;
关键词
glucococorticoids; muscle; skeletal; HPA-axis; cachexia; catabolism; wasting; protein synthesis; 1 NULL MICE; SKELETAL-MUSCLE; GENE-EXPRESSION; OXIDATIVE STRESS; DNA-BINDING; PROTEIN-DEGRADATION; PROTEOLYTIC SYSTEM; UBIQUITIN LIGASES; CANCER CACHEXIA; ATROPHY INVOLVE;
D O I
10.3389/fphys.2015.00012
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Glucocorticoids are highly conserved fundamental regulators of energy homeostasis. In response to stress in the form of perceived danger or acute inflammation, glucocorticoids are released from the adrenal gland, rapidly mobilizing energy from carbohydrate, fat and protein stores. In the case of inflammation, mobilized protein is critical for the rapid synthesis of acute phase reactants and an efficient immune response to infection. While adaptive in response to infection, chronic mobilization can lead to a profound depletion of energy stores. Skeletal muscle represents the major body store of protein, and can become substantially atrophied under conditions of chronic inflammation. Glucocorticoids elicit the atrophy of muscle by increasing the rate of protein degradation by the ubiguitin-proteasome system and autophagy lysosome system. Protein synthesis is also suppressed at the level of translational initiation, preventing the production of new myofibrillar protein. Glucocorticoids also antagonize the action of anabolic regulators such as insulin further exacerbating the loss of protein and muscle mass. The loss of muscle mass in the context of chronic disease is a key feature of cachexia and contributes substantially to morbidity and mortality. A growing body of evidence demonstrates that glucocorticoid signaling is a common mediator of wasting, irrespective of the underlying initiator or disease state. This review will highlight fundamental mechanisms of glucocorticoid signaling and detail the mechanisms of glucocorticoid-induced muscle atrophy. Additionally, the evidence for glucocorticoids as a driver of muscle wasting in numerous disease states will be discussed. Given the burden of wasting diseases and the nodal nature of glucocorticoid signaling, effective anti-glucocorticoid therapy would be a valuable clinical tool. Therefore, the progress and potential pitfalls in the development of glucocorticoid antagonists for muscle wasting will be discussed.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] In Vitro,In Vivo, andIn SilicoMethods for Assessment of Muscle Size and Muscle Growth Regulation
    Rupert, Joseph E.
    Jengelley, Daenique H. A.
    Zimmers, Teresa A.
    SHOCK, 2020, 53 (05): : 605 - 615
  • [32] Lipid modulation of skeletal muscle mass and function
    Lipina, Christopher
    Hundal, Harinder S.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2017, 8 (02) : 190 - 201
  • [33] Loss of mitochondrial energetics is associated with poor recovery of muscle function but not mass following disuse atrophy
    Trevino, Michelle B.
    Zhang, Xiaolei
    Standley, Robert A.
    Wang, Miao
    Han, Xianlin
    Reis, Felipe C. G.
    Periasamy, Muthu
    Yu, Gongxin
    Kelly, Daniel P.
    Goodpaster, Bret H.
    Vega, Rick B.
    Coen, Paul M.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2019, 317 (05): : E899 - E910
  • [34] Critical Roles of Endogenous Glucocorticoids for Disease Tolerance in Malaria
    Vandermosten, Leen
    Vanhorebeek, Ilse
    De Bosscher, Karolien
    Opdenakker, Ghislain
    Van den Steen, Philippe E.
    TRENDS IN PARASITOLOGY, 2019, 35 (11) : 918 - 930
  • [35] Glucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids
    Santen, Richard J.
    Jewell, Christine M.
    Yue, Wei
    Heitjan, Daniel F.
    Raff, Hershel
    Katen, Kevin S.
    Cidlowski, John A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (10) : 3630 - 3639
  • [36] Effects of Resveratrol on the Recovery of Muscle Mass Following Disuse in the Plantaris Muscle of Aged Rats
    Bennett, Brian T.
    Mohamed, Junaith S.
    Alway, Stephen E.
    PLOS ONE, 2013, 8 (12):
  • [37] Female-specific regulation of skeletal muscle mass by USP19 in young mice
    Ogawa, Masahiro
    Kitakaze, Tomoya
    Harada, Naoki
    Yamaji, Ryoichi
    JOURNAL OF ENDOCRINOLOGY, 2015, 225 (03) : 135 - 145
  • [38] Growth Hormone Secretagogues and the Regulation of Calcium Signaling in Muscle
    Bresciani, Elena
    Rizzi, Laura
    Coco, Silvia
    Molteni, Laura
    Meanti, Ramona
    Locatelli, Vittorio
    Torsello, Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)
  • [39] Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle
    Alamdari, Nima
    Smith, Ira J.
    Aversa, Zaira
    Hasselgren, Per-Olof
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2010, 299 (02) : R509 - R520
  • [40] The Hippo Signaling Pathway in the Regulation of Skeletal Muscle Mass and Function
    Watt, Kevin I.
    Goodman, Craig A.
    Hornberger, Troy A.
    Gregorevic, Paul
    EXERCISE AND SPORT SCIENCES REVIEWS, 2018, 46 (02): : 92 - 96